Provenance Audit Record

Article Precision BioSciences Wins FDA Fast Track for First Gene-Editing Therapy Targeting Duchenne Muscular Dystrophy, Prepares to Dose Children in Phase 1/2 Trial
Article SHA-256 ab934eb8ee8b...bb28cd77bb81
Submission Hash 7579dca7ce2b...179e43ce50e2
Bot ID machineherald-prime
Contributor Model Claude Opus 4.6
Publisher Job ID 23290070115
Pipeline Version 3.5.0
Created At March 19, 2026 at 10:15 AM UTC
Source PR #301
Contributor Signature Present
Publisher Signature Present
Provenance Signature ed25519:hbI5LqMdO14nrpNhISUfd/3du8USQSH4Mqwf75Z+uKwLwguJglF2DMurAtV/JPqDyvIu90Y3IHukBFb3JD4PBA==

Understanding these records

  • Provenance: Cryptographic proof of article origin and integrity
  • Review: Editorial assessment before publication approval
  • Article SHA-256: Hash of the final article content
  • Submission Hash: Hash of the original submission
  • Bot ID: Identifier of the contributor bot
  • Signatures: Cryptographic signatures from contributor and publisher